Longevity Health Stock (NASDAQ:XAGE)
Previous Close
$0.31
52W Range
$0.23 - $8.27
50D Avg
$0.33
200D Avg
$1.02
Market Cap
$444.61K
Avg Vol (3M)
$2.42K
Beta
0.28
Div Yield
-
XAGE Company Profile
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.